Sign Out
Ceftriaxone is susceptible the following organisms: Staphylococcus aureus (including beta-lactamase producing strains), Streptococcus pneumoniae, Staphylococcus epidermidis, Haemophilus influenzae, Haemophilus parainfluenzae, Escherichia coli, Proteus mirabilis, Pseudomonas aeruginosa, Proteus vulgaris, Proteus morganii, Neisseria gonorrhoeae, including both penicillinase - and nonpenicillinase-producing strains, Klebsiella pneumoniae. Streptococcus pyogenes, Clostridium species (excepting C. difficile), Serratia species, Salmonella species (including Salmonella typhi), Enterobacter species, Shigella species, Moraxella species. Group B streptococcus (Streptococcus agalactiae), Viridans group streptococci, Peptostreptococcus Haemophilus ducreyi, Neisseria meningitidis, Treponema pallidum, Fusobacterium, Bacteroides fragilis, Yersinia (including Yersinia enterocolitica), Providencia, Citrobacter, Alcaligenes, Aeromonas, Plesiomonas shigelloide.
Ceftriaxone is indicated for the treatment of the following infections: Lower Respiratory Tract Infections; Acute Bacterial Otitis Media; Skin and Skin Structure Infections; Urinary Tract Infections (complicated and uncomplicated); Uncomplicated Gonorrhea (cervical/urethral and rectal); Pelvic Inflammatory Disease caused by Neisseria gonorrhoeae; Bone and Joint Infections; Intra-Abdominal Infections; Meningitis, Septicemia.
Continue with Google